Viewing Study NCT01228760


Ignite Creation Date: 2025-12-25 @ 2:08 AM
Ignite Modification Date: 2025-12-26 @ 3:03 AM
Study NCT ID: NCT01228760
Status: COMPLETED
Last Update Posted: 2013-06-07
First Post: 2010-10-21
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study to Determine the Maximum Tolerated Dose of ASG-5ME in Subjects With Castration-Resistant Prostate Cancer
Sponsor: Astellas Pharma Inc
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module